Cancer Science

Aims & Scope

Cancer Science (formerly Japanese Journal of Cancer Research) is a monthly publication of the Japanese Cancer Association.

First published in 1907, the Journal continues to publish original articles, editorials, and letters to the editor, describing original research in the fields of basic, translational and clinical cancer research.

The Journal also accepts reports and case reports.

Cancer Science aims to present highly significant and timely findings that have a significant clinical impact on oncologists or that may alter the disease concept of a tumor.

The Journal will not publish case reports that describe a rare tumor or condition without new findings to be added to previous reports; combination of different tumors without new suggestive findings for oncological research; remarkable effect of already known treatments without suggestive data to explain the exceptional result.

Review articles may also be published.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	4.3
2024	4.50

Journal Rank

Year	Value
2024	2006

Journal Citation Indicator

Year	Value
2024	5814

SJR (SCImago Journal Rank)

Year	Value
2024	1.661

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	173

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• PubMed
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis

  Citation: 1108

  Authors: Nobuyoshi, Haruhisa, Takahiro

• Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?

  Citation: 836

  Authors: Yoshihiro, Hiroyoshi

• Reactive oxygen species in cancer: Current findings and future directions

  Citation: 674

  Authors: Hajime, Kohichi

• Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression

  Citation: 629

  Authors: Aristidis, Carl‐Henrik

• Oncolytic virus therapy: A new era of cancer treatment at dawn

  Citation: 623

  Authors: Hiroshi, Yasushi, Tomoki

• Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and1B1

  Citation: 616

  Authors: Tsutomu, Yoshiaki

• Epithelial–mesenchymal transition in cancer development and its clinical significance

  Citation: 597

  Authors: Masaaki, Koshi, Takehiko, Hideshi, Toru, Shoji, Hideo, Masaki

• A novel inflammation‐related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate

  Citation: 587

  Authors: Takuji, Hiroyuki, Rikako, Yasuhiro, Shigeyuki, Hideki

• Bystander killing effect of <scp>DS</scp>‐8201a, a novel anti‐human epidermal growth factor receptor 2 antibody–drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity

  Citation: 557

  Authors: Yusuke, Katsunobu, Masataka, Hiroyuki, Toshinori

• Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish

  Citation: 539

  Authors: Takashi, Keiji, Hitoshi, Minako

---